ALRS
Alerus Financial Corporation
ALRS's outlook is improving despite an expensive valuation.
JPM
JPMorgan Chase & Co.
JPM has the edge over ALRS overall, supported by stronger fundamentals and stronger valuation.
ALRS Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| N/A | |
| N/A |
ALRS's revenue and profitability are currently stable. Free cash flow and net leverage aren't meaningful measures for financial services companies like ALRS.
JPM Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
JPM's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like JPM.
ALRS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.5x | $11.26 | -67% |
| Fair | 12x | $13.75 | -60% |
| Forward | 12x | $34.27 | — |
| Current | 29x | $34.27 | — |
| Expensive | 35x | $41.75 | +22% |
Historical ranges are pointers, not guarantees.
ALRS's PE is in its expensive range at 29x. If earnings grow as analysts expect, today's price would be 12x next year's earnings, in its fair range.
JPM PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.7x | $231 | -33% |
| Fair | 12x | $287 | -16% |
| Current | 14x | $343 | — |
| Forward | 14x | $343 | — |
| Expensive | 15x | $361 | +5.2% |
Historical ranges are pointers, not guarantees.
JPM has the edge over ALRS in the historical PE scenario, which offers more potential upside but is not a forecast.
ALRS Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| High |
ALRS has the edge over JPM on the outlook, with more favorable valuation expectations.
JPM Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for JPM, with profitability improving.
ALRS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.86 | +140% |
| Q3 2026 | $1.19 | -37% |
| Q2 2026 | $1.08 | -28% |
| Q1 2026 | $1.05 | +1.9% |
| Q4 2025 | $0.68 | -18% |
| Q3 2025 | $1.89 | +1012% |
| Q2 2025 | $1.50 | +317% |
| Q1 2025 | $1.03 | +106% |
| Q4 2024 | $0.83 | +43% |
ALRS's earnings per share have fallen from their peak: $1.19 over the past year, against $3.14 in mid-2021.
JPM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $24.99 | +4.8% |
| Q3 2026 | $23.85 | +18% |
| Q2 2026 | $23.35 | +20% |
| Q1 2026 | $20.89 | +2.5% |
| Q4 2025 | $20.02 | +1.4% |
| Q3 2025 | $20.20 | +12% |
| Q2 2025 | $19.50 | +8.7% |
| Q1 2025 | $20.38 | +23% |
| Q4 2024 | $19.75 | +22% |
JPM's earnings per share have climbed steadily: $23.85 over the past year, up 18% from the year before, and higher year over year for 15 quarters in a row.
ALRS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $81.1M | +12% |
| Q2 2026 | $80.7M | +7.8% |
| Q1 2026 | $75.8M | +10% |
| Q4 2025 | $8.2M | -89% |
| Q3 2025 | $72.6M | +43% |
| Q2 2025 | $74.8M | +46% |
| Q1 2025 | $68.8M | +45% |
| Q4 2024 | $72.2M | +223% |
ALRS has the edge over JPM on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 31% | +0.5 points |
| Q2 2026 | 34% | -1.4 points |
| Q1 2026 | 40% | +14 points |
| Q4 2025 | -527% | -527 points |
| Q3 2025 | 30% | +17 points |
| Q2 2025 | 35% | +19 points |
| Q1 2025 | 26% | +7.6 points |
| Q4 2024 | -0.4% | +79 points |
ALRS's operating margin was 31% last quarter, about level with the same quarter a year ago.
JPM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $50.2B | +8.1% |
| Q2 2026 | $57.3B | +28% |
| Q1 2026 | $49.8B | +10% |
| Q4 2025 | $45.8B | +7.1% |
| Q3 2025 | $46.4B | +8.8% |
| Q2 2025 | $44.9B | -11% |
| Q1 2025 | $45.3B | +8.1% |
| Q4 2024 | $42.8B | +11% |
JPM's revenue has grown year over year for five quarters in a row: $50.2B last quarter, up 8.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 40% | -0.2 points |
| Q2 2026 | 48% | +7.3 points |
| Q1 2026 | 41% | +0.5 points |
| Q4 2025 | 37% | -3.2 points |
| Q3 2025 | 40% | +0.6 points |
| Q2 2025 | 41% | -6 points |
| Q1 2025 | 41% | -0.6 points |
| Q4 2024 | 41% | +11 points |
JPM has the edge over ALRS on profitability, with a higher operating margin.
ALRS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $52.7M | +74% |
| Q2 2026 | $17.9M | +137% |
| Q1 2026 | $25.8M | +356% |
| Q4 2025 | $15.3M | +241% |
| Q3 2025 | $30.3M | +87% |
| Q2 2025 | $7.6M | +$22.7M |
| Q1 2025 | $5.7M | -49% |
| Q4 2024 | $4.5M | +$7.5M |
ALRS has the edge over JPM on cash generation, producing positive trailing cash flow while its opponent burns cash.
JPM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $33.2B | +$78.4B |
| Q2 2026 | -$25.3B | -186% |
| Q1 2026 | -$211.8B | +$40.1B |
| Q4 2025 | $119.7B | -19% |
| Q3 2025 | -$45.2B | +$28.9B |
| Q2 2025 | $29.5B | -23% |
| Q1 2025 | -$251.8B | -$97.7B |
| Q4 2024 | $147.8B | +145% |
JPM's free cash flow was −$84.2B over the past year, against −$120B the year before. Free cash flow isn't a meaningful measure for financial services companies like JPM.
ALRS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.9% | -234K shares |
| 1 year | -2.1% | -552K shares |
| 3 years | +25% | +5.1M shares |
| 5 years | +44% | +7.7M shares |
| Available history | +67% | +10.1M shares |
ALRS has 25M diluted shares, down 2.1% from a year ago, with $22M in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $8.3M |
| Q2 2026 | $7.1M |
| Q1 2026 | $6.5M |
| Q4 2025 | $219,000 |
| Q3 2025 | $342,000 |
| Q2 2025 | $49,000 |
| Q1 2025 | $127,000 |
| Q4 2024 | $44,000 |
ALRS spent $22M buying back its own shares over the past year, more than ten times what it spent the year before.
JPM Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -11.2M shares |
| 1 year | -3.1% | -84.6M shares |
| 3 years | -8.5% | -249M shares |
| 5 years | -11% | -322M shares |
| Available history | -17% | -547M shares |
JPM has the edge over ALRS on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.1B |
| Q2 2026 | $6.8B |
| Q1 2026 | $8.3B |
| Q4 2025 | $8.3B |
| Q3 2025 | $8.3B |
| Q2 2025 | $7.5B |
| Q1 2025 | $7.5B |
| Q4 2024 | $4.3B |
JPM spent $24.5B buying back its own shares over the past year, down 11% from the year before.
ALRS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 5.9x | High |
| Q2 2026 | 5.8x | High |
| Q1 2026 | 2.6x | Moderate |
| Q4 2025 | 7.9x | High |
| Q3 2025 | 2.1x | Moderate |
| Q2 2025 | 4.6x | High |
| Q1 2025 | 4.0x | High |
| Q4 2024 | 7.2x | High |
ALRS's net debt is about 5.9 years of its operating earnings (EBITDA), up from 2.1 years a year ago. Net leverage isn't a meaningful measure for financial services companies like ALRS.
JPM Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.5x | Very low |
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.6x | Very low |
| Q4 2025 | 0.5x | Very low |
| Q3 2025 | 0.6x | Very low |
| Q2 2025 | 0.5x | Very low |
| Q1 2025 | 0.5x | Very low |
| Q4 2024 | 0.4x | Very low |
JPM has the edge over ALRS on leverage, with a lower net debt burden relative to earnings.
ALRS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 67.7 | Neutral |
| Stochastic | 74.9 | Neutral |
ALRS's weekly RSI is 68 (neutral) and its Stochastic is 75 (neutral).
JPM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.8 | Neutral |
| Stochastic | 31.5 | Neutral |
JPM's weekly RSI is 55 (neutral) and its Stochastic is 31 (neutral).
ALRS PE vs Financial Services Sector
| Metric | ALRS | Sector median | Relative |
|---|---|---|---|
| PE | 29x | 13x | 121% above |
| PE % | 76 | 63 | 13 pts above |
ALRS is trading at 29x earnings, a 121% premium to the Financial Services sector's median of 13x.
JPM PE vs Financial Services Sector
| Metric | JPM | Sector median | Relative |
|---|---|---|---|
| PE | 14x | 13x | 10% above |
| PE % | 76 | 63 | 13 pts above |
JPM has the edge over ALRS on valuation relative to its sector.
ALRS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $32.6 | 5.2% above |
| 20 week MA | $32.7 | 4.8% above |
| 50 week MA | $28.3 | 21% above |
| 100 week MA | $24.5 | 40% above |
| 200 week MA | $22.2 | 55% above |
ALRS has the edge over JPM on trend strength, trading above more of its moving averages.
JPM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $336.8 | 1.8% above |
| 20 week MA | $345.3 | 0.7% below |
| 50 week MA | $323.2 | 6.1% above |
| 100 week MA | $298.9 | 15% above |
| 200 week MA | $236.6 | 45% above |
JPM's trend is mixed: it's above four of its five weekly moving averages, and 45% above its 200-week average.
ALRS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $22.8 | $27.1 | +19% |
| 2021 | $27.1 | $29.5 | +8.9% |
| 2022 | $29.5 | $23.3 | -21% |
| 2023 | $23.3 | $22.4 | -3.9% |
| 2024 | $22.4 | $19.2 | -14% |
| 2025 | $19.2 | $21.8 | +13% |
| 2026 YTD | $21.8 | $34.3 | +57% |
ALRS has the edge over JPM on returns for 2026, with the stronger performance.
JPM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $139.1 | $124.5 | -11% |
| 2021 | $124.5 | $157.3 | +26% |
| 2022 | $157.3 | $131.3 | -17% |
| 2023 | $131.3 | $170.1 | +30% |
| 2024 | $170.1 | $241.2 | +42% |
| 2025 | $241.2 | $327.9 | +36% |
| 2026 YTD | $327.9 | $342.8 | +4.5% |
JPM has finished higher in four of the last six years. It's up 4.5% so far in 2026.